Pier Capital, LLC Adaptive Biotechnologies Corp Transaction History

Pier Capital, LLC

$568 Million
Q1 2025

A detailed history of Pier Capital, LLC transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Pier Capital, LLC holds 1,097,387 shares of ADPT stock, worth $13.3 Million. This represents 1.43% of its overall portfolio holdings.

Number of Shares

1,097,387

Previous 1,274,293 13.88%

Holding current value

$13.3 Million

Previous $7.65 Million 6.64%

% of portfolio

1.43%

Previous 1.15%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	SELL	$6.07 - $8.66 $1.07 Million - $1.53 Million	-176,906 Reduced 13.88%	1,097,387 $8.15 Million
Q4 2024 Feb 11, 2025	SELL	$4.37 - $6.78 $6,957 - $10,793	-1,592 Reduced 0.12%	1,274,293 $7.65 Million
Q3 2024 Nov 15, 2024	BUY	$3.37 - $5.12 $743,374 - $1.13 Million	220,586 Added 20.9%	1,275,885 $6.53 Million
Q2 2024 Aug 07, 2024	SELL	$2.34 - $3.96 $112,652 - $190,642	-48,142 Reduced 4.36%	1,055,299 $3.82 Million
Q1 2024 May 02, 2024	BUY	$2.88 - $4.8 $1.13 Million - $1.88 Million	392,334 Added 55.17%	1,103,441 $3.54 Million
Q4 2023 Feb 15, 2024	SELL	$3.46 - $5.33 $27,541 - $42,426	-7,960 Reduced 1.11%	711,107 $3.48 Million
Q3 2023 Nov 14, 2023	SELL	$5.07 - $8.44 $93,906 - $156,325	-18,522 Reduced 2.51%	719,067 $3.92 Million
Q2 2023 Aug 14, 2023	SELL	$6.19 - $8.78 $534,797 - $758,565	-86,397 Reduced 10.49%	737,589 $4.95 Million
Q1 2023 May 10, 2023	SELL	$7.8 - $10.11 $1.47 Million - $1.9 Million	-188,415 Reduced 18.61%	823,986 $7.28 Million
Q4 2022 Feb 15, 2023	BUY	$6.26 - $9.34 $1.15 Million - $1.72 Million	184,099 Added 22.23%	1,012,401 $7.73 Million
Q3 2022 Nov 15, 2022	BUY	$6.5 - $12.67 $3.18 Million - $6.2 Million	489,513 Added 144.49%	828,302 $5.9 Million
Q2 2022 Aug 15, 2022	SELL	$6.4 - $14.73 $4,812 - $11,076	-752 Reduced 0.22%	338,789 $2.74 Million
Q1 2022 May 10, 2022	BUY	$10.12 - $28.9 $1.45 Million - $4.14 Million	143,239 Added 72.97%	339,541 $4.71 Million
Q4 2021 Feb 10, 2022	SELL	$25.17 - $36.85 $29,952 - $43,851	-1,190 Reduced 0.6%	196,302 $5.51 Million
Q3 2021 Nov 10, 2021	SELL	$30.02 - $39.87 $66,194 - $87,913	-2,205 Reduced 1.1%	197,492 $6.71 Million
Q2 2021 Aug 12, 2021	BUY	$32.22 - $44.59 $1.38 Million - $1.91 Million	42,736 Added 27.23%	199,697 $8.16 Million
Q1 2021 May 13, 2021	BUY	$37.26 - $67.74 $372,339 - $676,925	9,993 Added 6.8%	156,961 $6.32 Million
Q4 2020 Feb 16, 2021	BUY	$45.01 - $65.47 $252,326 - $367,024	5,606 Added 3.97%	146,968 $8.69 Million
Q3 2020 Nov 13, 2020	BUY	$35.79 - $48.81 $906,668 - $1.24 Million	25,333 Added 21.83%	141,362 $6.87 Million
Q2 2020 Aug 13, 2020	BUY	$24.95 - $48.38 $2.89 Million - $5.61 Million	116,029 New	116,029 $5.61 Million

Others Institutions Holding ADPT

# of Institutions

246

Shares Held

156M

Call Options Held

44.3K

Put Options Held

47.8K

View Full List

About Adaptive Biotechnologies Corp

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $1.74B
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

More about ADPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pier Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pier Capital, LLC with notifications on news.

Account